TITLE

Prostat iğne biyopsisi ve radikal prostatektomi materyallerinde gleason skorlarının karşılaştırılması

AUTHOR(S)
Kürşat Bozkurt, Kemal; Kızmaz, Mustafa; İnan Mamak, Gülsün; Korkmaz, İsmail; Bircan, Sema
PUB. DATE
June 2013
SOURCE
Medical Journal of Suleyman Demirel University;2013, Vol. 20 Issue 3, p93
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Aim: Gleason score (GS) is an important prognostic marker for prostate cancer and it is strongly correlated with stage and prognosis. However, needle biopsy (NB) GS is not always consistent with that of radical prostatectomy (RP) specimens. In this study, the correlation of GSs of NB and RP specimens will be examined. Materials and Methods: Study population comprised of 51 patients who had diagnosed as adenocarcinoma by prostate NB and underwent RP operation. The GSs of both specimens were compared and their correlation was investigated. In addition, the effect of blood prostate-specific antigen (PSA) levels and number of tumor positive quadrants in NBs on the correlation was also examined. Results: Gleason scores of NBs were 6, 7 and 9 in 43 (84.3%), 7 (13.7%) and I (2%) patients respectively. Exact correlation existed between GSs of NB and RP specimens for 35 (68.6%) cases. Positive predictive values for biopsy GSs 6 and 7 were 65.1% and 100%, respectively. Fifteen (29.4%) biopsies were undergraded and 1 (2%) was overgraded. Blood PSA levels and number of tumor positive quadrants in prostate NBs did not affect GS correlation (p>0.05). Conclusion: Gleason scoring system is an important parameter on determining the treatment and prognosis in prostate cancer. Thereby, it is important to provide a correlation between GSs of prostate NBs and RP specimens for the treatment.
ACCESSION #
94903609

 

Related Articles

  • The Role of Radical Prostatectomy in the Treatment of Patients with High-Risk Prostate Cancer. Kuzgunbay, Barış; Yaycıoğlu, Özgür // Journal of Urological Surgery;Sep2015, Vol. 2 Issue 3, p120 

    High-risk prostate cancer (PCa), which is defined as PSA >20 ng/mL or Gleason Score (GS) >7 or ≥cT3a, accounts for up to 40% of newly diagnosed cases and carries a significant risk of progression and death. However, the best management approach for patients with high-risk PCa is still...

  • High Risk Prostate Cancer: the Best Indication for Radical Prostatectomy. Van Poppel, Hendrik // AUANews;Apr2013, Vol. 18 Issue 4, p20 

    The article reports that as of 2013, the radical treatment options for high risk prostate cancer (Pca) are radiotherapy (RT) and radical prostatectomy (RP). Since 10-year cancer specific survival (CSS) rates of more than 90% have been described, surgery for high risk Pca is gaining popularity. A...

  • Robots Have Not Made a Difference in Outcomes of Patients with Prostate Cancer. Nelson, Joel B. // AUANews;Sep2014, Vol. 19 Issue 9, p22 

    The author discusses why robots have not made a difference in the outcomes of prostate cancer patients. Issues mentioned include the three reasons for the failure of radical prostatectomy to cure prostate cancer which are tumor biology and surgical technique and evidence which shows that Gleason...

  • Radical Prostatectomy is a Valuable Treatment Alternative in Patients with High-Risk Prostate Cancer. Mangır, Naşide; Top, Tuncay; Tinay, İlker; Tanıdır,, Yılören; Türkeri, Levent // Journal of Urological Surgery;Sep2015, Vol. 2 Issue 3, p124 

    Objective To review the high-risk prostate cancer (PCa) patient database with special emphasis on the role of radical prostatectomy (RP) in comparison to external beam radiotherapy (EBRT). Materials and Methods A total of 102 patients with complete and long-term follow-up data were included....

  • Controversies associated with the evaluation of elderly men with localized prostate cancer when considering radical prostatectomy. Mitsuzuka, Koji; Arai, Yoichi // International Journal of Clinical Oncology;Oct2014, Vol. 19 Issue 5, p793 

    The incidence of prostate cancer in Japan is increasing due to both the spread of screening and the rapid aging of the population. Most of this increase is expected to be attributable to the increase in the elderly male population. The management of various types of cancers in elderly patients...

  • Surgery and the Reduction of Mortality from Prostate Cancer. Walsh, Patrick C. // New England Journal of Medicine;9/12/2002, Vol. 347 Issue 11, p839 

    Editorial. Considers the need for studies that measure the effectiveness of aggressive management of localized prostate cancer. Response to a study conducted by Holmberg et al; Importance of both watchful waiting and radical prostatectomy surgery; Suggestion that patients seek radiation therapy.

  • Can Prostate-Specific Antigen Kinetics before Prostate Biopsy Predict the Malignant Potential of Prostate Cancer? Sang Jin Kim; Tae Yoong Jeong; Dae Seon Yoo; Jinsung Park; Seok Cho; Seok Ho Kang; Sang Hyub Lee; Seung Hyun Jeon; Tchun Yong Lee; Sung Yul Park // Yonsei Medical Journal;Nov2015, Vol. 56 Issue 6, p1492 

    Purpose: To predict the malignant potential of prostate cancer (PCa) according to prostate-specific antigen velocity (PSAV), PSA density (PSAD), free/total PSA ratio (%fPSA), and digital rectal examination (DRE). Materials and Methods: From January 2009 to December 2012, 548 adult male patients...

  • The need for, and utilization of prostate-bed radiotherapy after radical prostatectomy for patients with prostate cancer in British Columbia. Tyldesley, Scott; Peacock, Michael; Morris, James W.; So, Alan; Kim-Sing, Charmaine; Quirt, Jill; Carter, Michael; Pickles, Tom // Canadian Urological Association Journal;Apr2012, Vol. 6 Issue 2, p89 

    Introduction: Three randomized trials have demonstrated that post-radical prostatectomy (RP) radiotherapy decreases biochemical relapse for those with adverse pathology. Our purpose was to describe the incidence of pathologic risk factors for recurrence in a contemporary series of patients...

  • Personal preferences and discordant prostate cancer treatment choice in an intervention trial of men newly diagnosed with localized prostate cancer. Bosco, Jaclyn L. F.; Halpenny, Barbara; Berry, Donna L. // Health & Quality of Life Outcomes;2012, Vol. 10 Issue 1, p123 

    Background: Men diagnosed with localized prostate cancer (LPC) can choose from multiple treatment regimens and are faced with a decision in which medical factors and personal preferences are important. The Personal Patient Profile-Prostate (P3P) is a computerized decision aid for men with LPC...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics